name | 俞孟君 |
sex | male
|
age | 65 岁 |
hospital number | 893829 |
height | 170 cm |
weight | 65 kg |
BSA | 1.75 m2 |
APACHEⅡ | 14 分 |
Infection source | abdominal
|
date | 2017.7.18 年/月/日 |
Sequential Organ Failure Assessment | 16 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | |
yes
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
比阿培南0.6 q12h,替考拉宁0.4 qd |
|
vasoactive agent | norepinephrine
|
60 min |
|
80 min |
|
240 min |
Temperature | 37.2 ℃ |
Heart Rate | 84 次/分 |
Breath | 15 次/分 |
Systolic pressure (SP) | 136 mmHg |
Diastolic pressure | 66 mmHg |
mean arterial pressure | 90 mmHg |
Pcv-aCO2 | 14.9 mmHg |
DO2 | 462 |
VO2 | 187.7 |
Ca-vO2 | 47 |
pH value | 7.31 |
PaO2 | 176 mmHg |
PaCO2 | 28.3 mmHg |
BE | -11 mmol/L(±2.3mmol/L) |
SaO2 | 99.5 % |
Blood lactic acid concentration, LAC | 3.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 440 mmHg |
pH value | 7.2 |
PcvO2 | 33.3 mmHg |
PcvCO2 | 43.2 mmHg |
BE | -10.5 mmol/L |
ScvO2 | 59 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 10 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 10 mmHg |
cardiac output | 3.99 L/min |
cardiac index | 2.28 L/min/m2 |
stroke volume | 47.5 ml |
Stroke Index | 27.1 ml/m2 |
ITBVI | 614 ml/m2 |
GEDVI | 491 ml/m2 |
EVLWI | 4.5 ml/kg |
PVPI | 1.3 |
SVRI | 2806 DSm2/cm5 |
CFI | 5 |
GEF | 23 % |
SVV | 10 % |
PPV | % |
dPmax | 1451 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 3 条 |
LUS | 5 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 12 mm |
respiratory variations of inferior vena cavae diameter | % |
15 mm |
|
13 mm |
|
12 mm |
|
10 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.9 ℃ |
Heart Rate | 96 次/分 |
Breath | 17 次/分 |
Systolic Pressure | 143 mmHg |
Diastolic Pressure | 70 mmHg |
Mean Arterial Pressure | 97 mmHg |
Pcv-aCO2 | 6.6 mmHg |
DO2 | 544 |
VO2 | 127 |
Ca-vO2 | 22.5 |
PH value | 7.35 |
PaO2 | 150 mmHg |
PaCO2 | 33.5 mmHg |
BE | -6.5 mmol/L |
SaO2 | 99.6 % |
Blood Lactic Acid Concentration | 2.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 375 mmHg |
PH value | 7.31 |
PcvO2 | 41.5 mmHg |
PcvCO2 | 40.1 mmHg |
BE | -5.5 mmol/L |
ScvO2 | 76 % |
Volume of input | 5934 ml |
Volume of output | 2350 ml |
Volume of urine | 1650 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 10 mg |
Dopamine Dosage | 0 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 6 mmHg |
cardiac output | 5.67 L/min |
cardiac index | 3.24 L/min/m2 |
stroke volume | 59.1 ml |
Stroke Index | 33.8 ml/m2 |
ITBVI | 690 ml/m2 |
GEDVI | 552 ml/m2 |
EVLWI | 4.1 ml/kg |
PVPI | 1.6 |
SVRI | 2147 DSm2/cm5 |
CFI | 6 |
GEF | % |
SVV | 5 % |
PPV | 10 % |
dPmax | 1157 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 3 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19 mm |
IVC(expiratory phase) | 17 mm |
Respiratory variations of inferior vena cavae diameter | % |
17 mm |
|
15 mm |
|
15 mm |
|
13 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.7 ℃ |
Heart Rate | 98 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 158 mmHg |
Diastolic Pressure | 75 mmHg |
Mean Arterial Pressure | 107 mmHg |
Pcv-aCO2 | 7.6 mmHg |
DO2 | 511 |
VO2 | 104 |
Ca-vO2 | 18.5 |
PH value | 7.36 |
PaO2 | 138 mmHg |
PaCO2 | 32 mmHg |
BE | -6.6 mmol/L |
SaO2 | 99.6 % |
Blood Lactic Acid Concentration | 2.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 345 mmHg |
PH value | 7.31 |
PcvO2 | 46 mmHg |
PcvCO2 | 39.6 mmHg |
BE | -6 mmol/L |
ScvO2 | 79.8 % |
Volume of input | 7121 ml |
Volume of output | 3770 ml |
Volume of urine | 2700 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 18 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 4 mmHg |
cardiac output | 5.64 L/min |
cardiac index | 3.22 L/min/m2 |
stroke volume | 57.6 ml |
Stroke Index | 32.9 ml/m2 |
ITBVI | 662 ml/m2 |
GEDVI | 530 ml/m2 |
EVLWI | 3.5 ml/kg |
PVPI | 0.9 |
SVRI | 2630 DSm2/cm5 |
CFI | 6 |
GEF | 26 % |
SVV | 6 % |
PPV | 0.9 % |
dPmax | 1114 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 15 mm |
Respiratory variations of inferior vena cavae diameter | % |
17 mm |
|
15 mm |
|
15 mm |
|
13 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.6 ℃ |
Heart Rate | 101 次/分 |
Breath | 15 次/分 |
Systolic Pressure | 154 mmHg |
Diastolic Pressure | 75 mmHg |
Mean Arterial Pressure | 106 mmHg |
Pcv-aCO2 | 3.2 mmHg |
DO2 | 621 |
VO2 | 114 |
Ca-vO2 | 19.8 |
PH value | 7.4 |
PaO2 | 130 mmHg |
PaCO2 | 34.7 mmHg |
BE | -3 mmol/L |
SaO2 | 99.4 % |
Blood Lactic Acid Concentration | 2.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 325 mmHg |
PH value | 7.37 |
PcvO2 | 45.5 mmHg |
PcvCO2 | 37.9 mmHg |
BE | -3.2 mmol/L |
ScvO2 | 81.3 % |
Volume of input | 1818 ml |
Volume of output | 1270 ml |
Volume of urine | 1200 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 5.76 L/min |
cardiac index | 3.29 L/min/m2 |
stroke volume | 57 ml |
Stroke Index | 32.6 ml/m2 |
ITBVI | 614 ml/m2 |
GEDVI | 491 ml/m2 |
EVLWI | 4 ml/kg |
PVPI | 1.1 |
SVRI | 2284 DSm2/cm5 |
CFI | 7 |
GEF | 27 % |
SVV | 2 % |
PPV | % |
dPmax | 1000 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 1 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19 mm |
IVC(expiratory phase) | 18 mm |
Respiratory variations of inferior vena cavae diameter | % |
16 mm |
|
13 mm |
|
15 mm |
|
13 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37 ℃ |
Heart Rate | 92 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 175 mmHg |
Diastolic Pressure | 82 mmHg |
Mean Arterial Pressure | 119 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 593 |
VO2 | 93 |
Ca-vO2 | 18.2 |
PH value | 7.41 |
PaO2 | 78.6 mmHg |
PaCO2 | 36.2 mmHg |
BE | -1.1 mmol/L |
SaO2 | 96.5 % |
Blood Lactic Acid Concentration | 1.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 196.5 mmHg |
PH value | 7.38 |
PcvO2 | 35.6 mmHg |
PcvCO2 | 43.2 mmHg |
BE | 0.3 mmol/L |
ScvO2 | 63.5 % |
Volume of input | 3218 ml |
Volume of output | 4100 ml |
Volume of urine | 3900 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 18 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 5.11 L/min |
cardiac index | 2.92 L/min/m2 |
stroke volume | 55.5 ml |
Stroke Index | 31.7 ml/m2 |
ITBVI | 654 ml/m2 |
GEDVI | 523 ml/m2 |
EVLWI | 3.9 ml/kg |
PVPI | 1 |
SVRI | 2985 DSm2/cm5 |
CFI | 6 |
GEF | 25 % |
SVV | 4 % |
PPV | % |
dPmax | 1045 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 16 mm |
IVC(expiratory phase) | 13 mm |
Respiratory variations of inferior vena cavae diameter | % |
13 mm |
|
10 mm |
|
10 mm |
|
9 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.2 ℃ |
Heart Rate | 73 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 156 mmHg |
Diastolic Pressure | 70 mmHg |
Mean Arterial Pressure | 102 mmHg |
Pcv-aCO2 | 3.9 mmHg |
DO2 | 454 |
VO2 | 78.5 |
Ca-vO2 | 19.6 |
PH value | 7.43 |
PaO2 | 123 mmHg |
PaCO2 | 35.3 mmHg |
BE | -0.4 mmol/L |
SaO2 | 99.3 % |
Blood Lactic Acid Concentration | 2.3 mmol/L |
Oxygenation index (PaO2/FiO2) | 410 mmHg |
PH value | 7.4 |
PcvO2 | 46.3 mmHg |
PcvCO2 | 39.2 mmHg |
BE | -0.1 mmol/L |
ScvO2 | 82.6 % |
Volume of input | 2589 ml |
Volume of output | 3201 ml |
Volume of urine | 1580 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 18 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 19 mmHg |
cardiac output | 4.01 L/min |
cardiac index | 2.17 L/min/m2 |
stroke volume | 48.7 ml |
Stroke Index | 29.7 ml/m2 |
ITBVI | 699 ml/m2 |
GEDVI | 559 ml/m2 |
EVLWI | 3.2 ml/kg |
PVPI | 0.8 |
SVRI | 3062 DSm2/cm5 |
CFI | 5 |
GEF | 23 % |
SVV | 8 % |
PPV | % |
dPmax | 976 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 1 条 |
LUS | 3 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 17 mm |
Respiratory variations of inferior vena cavae diameter | % |
IVC(inspiratory phase) | 13 mm |
15 mm |
|
12 mm |
|
13 mm |
|
10 mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 224 pg/ml |
BNP | pg/ml |
cTNI | 0.045 ng/ml |
Creatine kinase isoenzyme, CKMB | 63 U/L |
Creatinine | 90 umol/L |
Urea nitrogen | 6.5 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 4.1 X10*9/L |
neutrophilic granulocyte percentage | 87.3 % |
Hb | g/L |
CRP | 105.1 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 16 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 1236 pg/ml |
BNP | pg/ml |
cTNI | 0.018 ng/ml |
Creatine kinase isoenzyme, CKMB | 50 U/L |
Creatinine | 105 umol/L |
Urea nitrogen | 9.1 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 25.8 X10*9/L |
neutrophilic granulocyte percentage | 96.4 % |
Hb | g/L |
CRP | 191.93 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Sequential Organ Failure Assessment | 10 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 2576 pg/ml |
BNP | pg/ml |
cTNI | 0.067 ng/ml |
Creatine kinase isoenzyme, CKMB | 32 U/L |
Creatinine | 105 umol/L |
Urea nitrogen | 9.1 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 30 X10*9/L |
neutrophilic granulocyte percentage | 95.9 % |
Hb | g/L |
CRP | 322.77 mg/L |
Procalcitonin, PCT | 32.84 ng/ml |
Sequential Organ Failure Assessment | 5 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | yes
|
Plasma infusion | 1200 ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 8 分 |
Complication | no
|
prognosis | improve
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 30 天 |
duration in ICU | 3 天 |
duration of mechanical ventilation | 28 小时 |
ICU expenses | 18576 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |